← Back to Clinical Trials
Recruiting NCT05689944

NCT05689944 Dance-therapy and Chronic Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05689944
Status Recruiting
Phase
Sponsor Hospices Civils de Lyon
Condition Chronic Pain
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2024-03-01
Primary Completion 2030-10

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 20 Years
Study Type INTERVENTIONAL
Interventions
Dance-therapyArt-therapyYoga

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2024-03-01 with a primary completion date of 2030-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pain, when it becomes chronic, can be a threat to patients and it is very common to observe a fear of pain and a fear of movement (kinesiophobia). Avoidance of movement due to fear of pain can lead to a deterioration of body image. Non-medicinal therapies are essential to correct this fear and movement avoidance behavior, to decrease "catastrophic" judgments and thus anxiety. The use of art-therapy in the accompaniment of patients with pain has shown, in particular, decreases in the intensity of pain, the level of anxiety, an improvement in stress, mood and overall psychological state. However, according to the current literature, it appears that 1) this technique is rarely used in children or adolescents, for whom non-medicinal therapies are fundamental, and 2) in the case of chronic pain, the form of art used is very rarely related to the body (most often painting, drawing, music...). In this project, investigators propose to set up and test the potential benefit of art-therapy sessions related to the body, namely dance-therapy, in adolescents and young adults suffering from chronic pain.

Eligibility Criteria

Inclusion Criteria: * Patients aged 12 to 20 years, girls or boys, with chronic pain. * Diagnosis of chronic pain made in a Pain Management Center * Patients followed in a Pain Management Center (to ensure that patients entering the protocol have pain that is not relieved by conventional treatments) * Patients who have given written consent for adults or whose parents have given consent for minors * Patients who are affiliated with or benefit from a social security system. Exclusion Criteria: * Patients with other neurological or psychological disorders * Patients with psychiatric illnesses * Patients with chronic infectious, metabolic, cancerous, autoimmune diseases. * Non-communicating patients including deaf and hard of hearing patients * Patients or parents who do not speak or read French * Pregnant women * Dance or yoga professionals (dance or yoga teachers or those studying to become teachers)

Contact & Investigator

Central Contact

Maud FROT, INSERM Researcher

✉ maud.frot@univ-lyon1.fr

📞 04 72 35 78 88

Frequently Asked Questions

Who can join the NCT05689944 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 20 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05689944 currently recruiting?

Yes, NCT05689944 is actively recruiting participants. Contact the research team at maud.frot@univ-lyon1.fr for enrollment information.

Where is the NCT05689944 trial being conducted?

This trial is being conducted at Bron, France.

Who is sponsoring the NCT05689944 clinical trial?

NCT05689944 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 160 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology